Nanosphere Health Sciences (XCNQ:NSHS) Debt-to-Equity : -0.02 (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Nanosphere Health Sciences Debt-to-Equity?

Nanosphere Health Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$0.04 Mil. Nanosphere Health Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$0.00 Mil. Nanosphere Health Sciences's Total Stockholders Equity for the quarter that ended in Sep. 2024 was C$-2.28 Mil. Nanosphere Health Sciences's debt to equity for the quarter that ended in Sep. 2024 was -0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nanosphere Health Sciences's Debt-to-Equity or its related term are showing as below:

XCNQ:NSHS' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.16 Med: -0.03 Max: 0.42
Current: -0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Nanosphere Health Sciences was 0.42. The lowest was -0.16. And the median was -0.03.

XCNQ:NSHS's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.14 vs XCNQ:NSHS: -0.02

Nanosphere Health Sciences Debt-to-Equity Historical Data

The historical data trend for Nanosphere Health Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences Debt-to-Equity Chart

Nanosphere Health Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.16

-0.05

Nanosphere Health Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-0.02	-0.02

Competitive Comparison of Nanosphere Health Sciences's Debt-to-Equity

For the Biotechnology subindustry, Nanosphere Health Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosphere Health Sciences's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Debt-to-Equity falls into.

Nanosphere Health Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nanosphere Health Sciences's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-2.088
	=	0.00

Nanosphere Health Sciences's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.043	+	0)	/	-2.281
	=	-0.02

Nanosphere Health Sciences (XCNQ:NSHS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Nanosphere Health Sciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosphere Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (XCNQ:NSHS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

NSHSF:USA 2CG2:Germany 2CG:Germany

Address

1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7

Website

https://www.nanospherehealth.com

Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.

Nanosphere Health Sciences Headlines

No Headlines